Dalteparin sodium - Pfizer
Alternative Names: Boxol; FR 860; Fragmin; Fragmine; KABI 2165; KV 2165; Tedelparin; TedelparineLatest Information Update: 30 Jan 2024
At a glance
- Originator Pfizer
- Class Antithrombotics; Low molecular weight heparins
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Acute coronary syndromes; Deep vein thrombosis; Thromboembolism
- Registered Venous thromboembolism
Most Recent Events
- 09 Dec 2023 The efficacy data from a phase III Kids-DOTT trial in acute venous thrombosis presented at the 65th American Society of Hematology Annual Meeting and Exposition (ASH-2023)
- 13 Jun 2019 Safety data from a phase II trial in presented at the 24th Congress of the European Haematology Association (EHA-2019)
- 16 May 2019 Preregistration for Venous thromboembolism (In adolescents, In children, In infants) in USA (SC) prior to May 2019